Tariff refunds helped deliver a profit beat during Costco’s fourth quarter.
Results
-
-
Talon Metals’ (TSX:TLO,OTCID:TLOFF) share price surged 29 percent after it released results showing a record intercept at its Tamarack project in Minnesota, US, on Wednesday (September 9). The drill hole,…
-
Investment
Mining Stock Scorpio Gold (NASDAQ: SGLD) (TSXV: SGLD) Makes Nasdaq Top Gainer List on Drill Results Following Nasdaq Listing
Scorpio Gold’s ADSs began trading on Nasdaq under SGLD, and the stock is topping the exchange’s gainers list after new high-grade drill results from the Manhattan District. Investorideas.com (www.investorideas.com), a…
-
Blue Moon Metals Inc. press release (MOON:CA): Reported a net loss attributable to shareholders of $56,376,146 ($0.63 per common share) for the six months ended June 30. Exploration expenditures increased…
-
An 18% revenue surge and blowout 2027 forecast weren’t enough to sustain Cisco’s stock momentum.
-
monkeybusinessimages/iStock via Getty Images AbCellera Biologics (ABCL) is up ~35% in Monday morning trading after announcing top-line phase 2 data for ABCL635, its candidate for moderate-to-severe vasomotor symptoms (hot flashes)…
-
Investment
ParkwayLife Reit – Tuesday, 4th August whe is going to released her 1st Half results. Estimating DPU of 8.5 to 8.7 cents. The results will be out before trading commence
ParkwayLife Reit – Tuesday, 4th August whe is going to released her 1st Half results. Estimating DPU of 8.5 to 8.7 cents. The results will be out before trading commence.…
-
Investment
Data Center Stock Digital Realty (NYSE: DLR) Makes NYSE Top Gainer List on Second Quarter Results
Shares jumped over 14% after the data center REIT posted record Core FFO per share and raised its full-year outlook. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas including AI…
-
Investment
Tvardi Therapeutics (Nasdaq: TVRD) Soars on Positive Phase 1 Results for Next-Gen STAT3 Inhibitor TTI-109
Tvardi’s next-generation STAT3 inhibitor TTI-109 confirmed rapid prodrug conversion, dose-proportional exposure, and improved tolerability versus TTI-101 in Phase 1 testing. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas, including biotech…
-
Published on May 20, 2026 Share JOIN OUR FREE TELEGRAM SERVER TODAY Real-time stock alerts across Mining, Crypto, AI/Tech, Defense &…
